Kodiak Sciences (KOD) Stock Price Today, Pre-Market & After-Hours

Data

Supercharts

Legend

Watchlist

Kodiak Sciences Inc

KOD

Nasdaq

Health Technology

Biotechnology

85.75

USD

-2.37

-2.69%

Closed: 10-16 20:00 (UTC+0)

85.00

USD

-0.75

-0.87%

After Hours: 10-17 00:00 (UTC+0)

KOD Key Statistics

High

89.78

Open

87.18

Volume

1.12M

Low

85.20

Prev. Close

88.12

Trading Value

97.70M

52-Week High

104.00

Relative Volume

0.321

Amplitude (%)

5.20%

52-Week Low

13.95

Turnover Rate

1.79%

Market Cap

5.38B

P/E Ratio (TTM)

P/E Ratio (Annual)

P/B Ratio

90.65

P/S Ratio

Earnings Per Share (EPS)

-4.193

Dividend (TTM)

Dividend Yield

0.00%

Shares Outstanding

62.84M

Currency Unit

USD

KOD Price Performance

7 day

30 day

90 day

180 day

Year to date

1 Year

KOD Money Flow Distribution

KOD Daily Short Sale Volume

KOD Short Interest History

KOD Stock Snapshot

As of 2026-10-17, the Kodiak Sciences Inc (KOD) stock price today is 85.75. Based on this price, the company has a market capitalization of $5.38B, with a P/E ratio of --. On 2026-10-17, KOD traded between 85.20 and 89.78. Today’s stock price is 0.65% above the daily low and 4.49% below the daily high, placing KOD near the lower end of its most recent trading range. Trading volume currently stands at 1.12M, compared with an average daily volume of 3.50M. This suggests that trading activity is significantly below its usual level than usual. Over the past year, Kodiak Sciences Inc shares have traded between 13.95 and 104.00. At today’s price, KOD is 514.70% above its 52-week low and 17.55% below its 52-week high.

KOD Related News

About KOD

Company Name

Kodiak Sciences Inc

Sector

Health Technology

Industry

Biotechnology

Exchanges

Nasdaq

Number of Employees

124

Lot Size

100

Official Website

www.kodiak.com

Currency Unit

USD

Kodiak Sciences Inc (KOD) is a clinical-stage biopharmaceutical company developing antibody-biopolymer conjugate medicines for retinal diseases. Its programs include tarcocimab and other long-acting therapies for macular degeneration and diabetic eye disease. Its pipeline also includes KSI-501, a bispecific IL-6/VEGF trap, and KSI-101, a high-strength bispecific protein targeting IL-6 and VEGF.

Related Stocks

KOD FAQ

1.What is the live stock price of Kodiak Sciences Inc (KOD) today?

3. What were KOD’s trading range and trading volume on the most recent trading day?

What is the latest after-hours price of KOD?

7. What are KOD’s 52-week high and 52-week low?

9. What are KOD’s short sale volume and short interest?

11. What are Kodiak Sciences Inc’s P/E ratio and valuation metrics?

13. What were Kodiak Sciences Inc’s revenue and net income in the most recent quarter?

15.What is Kodiak Sciences Inc’s total number of shares outstanding?

17. Which exchange is Kodiak Sciences Inc listed on, and what sector and industry does it belong to?

19. What risks should investors consider before investing in KOD?

2.What is the ticker symbol for Kodiak Sciences Inc?

4. What is the latest pre-market price of KOD?

6.How has KOD’s stock price performed recently?

8. What is the current capital flow for KOD?

10. What is the current price of NVDA stock perps?

12. What is the market capitalization of Kodiak Sciences Inc?

14. What is Kodiak Sciences Inc’s earnings per share (EPS)?

16. Does Kodiak Sciences Inc pay dividends?

18. How many employees does Kodiak Sciences Inc have?